Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Pfizer (PFE) Ascends While Market Falls: Some Facts to Note
06:50pm, Wednesday, 04'th Sep 2024
In the most recent trading session, Pfizer (PFE) closed at $28.39, indicating a +0.32% shift from the previous trading day.
Pfizer Inc. (PFE) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
02:32pm, Wednesday, 04'th Sep 2024
Pfizer Inc. (NYSE:PFE ) Morgan Stanley 22nd Annual Global Healthcare Conference September 4, 2024 8:30 AM ET Company Participants David Denton - Chief Financial Officer Conference Call Participants Te
3 Bargain-Priced Growth Stocks for Fall 2024
07:32am, Wednesday, 04'th Sep 2024
While market volatility may initially unsettle investors, it presents an opportunity to capitalize on discounted investment prospects. While the current bull market has favored some sectors, it hasn't
Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases Pfizer Igni
Look Out, Pfizer and Merck. Vaxcyte Posts Strong Pneumococcal Vaccine Data.
10:48am, Tuesday, 03'rd Sep 2024
At the highest dose tested, Vaxcyte's shot elicited a stronger immune response against 18 of the 20 strains compared with Pfizer's.
Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine
06:50am, Tuesday, 03'rd Sep 2024
The Phase 2 trial was evaluating the vaccine called VLA15 following a second booster dose given one year after the first one.
The Economy Is Turning Ugly: 6 High-Yield Dividend Giants to the Rescue
06:12am, Tuesday, 03'rd Sep 2024
24/7 Wall St. Insights With bond yields falling, high-yield dividend stocks look enticing now.
Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate
01:00am, Tuesday, 03'rd Sep 2024
Saint-Herblain (France) and New York, NY, September 3, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) and Pfizer Inc. (NYSE: PFE) announced today positive immunogenicity and safety data f
Pfizer Stock: Graham P/E Shows Large Discounts
04:25pm, Friday, 30'th Aug 2024
I view Pfizer Inc. as a leader in a defensive sector under temporary ROCE pressure. Its profit recovery and growth prospects are substantially underestimated by the prevailing market consensus. Even a
Pfizer: Look Beyond COVID-19 And The Patent Cliffs - Robust Long-Term Tailwinds
04:00pm, Friday, 30'th Aug 2024
PFE's bullish support has already been observed at the $25s, with the worst seemingly well behind us. Its core portfolio continues to generate robust growth at +14% YoY in FQ2'24 (excluding Comirnaty
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:06am, Friday, 30'th Aug 2024
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
2 Incredibly Cheap Growth Stocks to Buy Now
05:45am, Friday, 30'th Aug 2024
Stock market prices don't tell you everything, and that's certainly true with these businesses. Pfizer is paving the way to future growth, but investors might need to be patient.
2 Incredibly Cheap Healthcare Stocks to Buy Now
04:20am, Friday, 30'th Aug 2024
Both of these stocks have something to offer income-seeking investors. AbbVie is moving on from the loss of patent exclusivity for the world's top-selling drug.
Why Is Pfizer (PFE) Down 5.9% Since Last Earnings Report?
12:37pm, Thursday, 29'th Aug 2024
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
01:11pm, Wednesday, 28'th Aug 2024
PFE's digital pharmacy aims to provide patients easy access to its medicines for COVID-19, migraine and other conditions.
